It was shown that in the group of healthy individuals, CS100B ≥ 7.8 pg/mL was detectable in only 2% of participants, which may result from emerging neurological disorders, especially in one of two individuals with very high S100B levels (11,270 pg/mL). The gene discussed is S100B; the disease is nervous system disorder.